New Alzheimer’s guidelines provide comprehensive framework for diagnosis

We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer’s disease (AD) and AD-related neurodegenerative disorders (ADRD) that are rapidly impacting evaluation and care paradigms in every clinical setting: primary care, specialty care and dementia subspecialty care.

Livanova hits sleep apnea trial goals, plans FDA filing

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Livanova said Monday a trial

November 13, 2024

Study: Firearm injury prevention policies need to be implemented properly to be effective

When evidence-based firearm injury prevention policies such as extreme risk protection orders are implemented properly, they can play a significant role in preventing gun-related injuries

August 14, 2023

Eli Lilly reveals two-year data for experimental eczema treatment after FDA roadblock

Eli Lilly is bolstering the case for its experimental eczema treatment lebrikizumab with a first look at how patients fared after two years of maintenance

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.